FDA Warns Medical Device Bluetooth Security Flaw Could Disrupt Function

HealthITSecurity | March 05, 2020

A set of cybersecurity flaws found in a range of medical devices with Bluetooth Low Energy (BLE) could allow a hacker to remotely crash a device or access its data, according to a recent alert from the Food and Drug Administration. The BLE is used to pair and exchange data between two devices to perform specific functions and preserve battery life. However, researchers discovered a flaw, dubbed SweynTooth, that could allow a hacker to remotely crash the device, stop its function, or access functions typically only available to the authorized user. The vulnerability affects the BLE wireless communication technology found in certain products designed by several microchip manufacturers, including Texas Instruments, NXP, Cypress, Dialog Semiconductors, Microchip, STMicroelectronics, and Telink Semiconductor.

Spotlight

Julia Weidman, Marketing Manager at Carestream, outlines the value of HIMSS Analytics and highlights the services they provided which enhanced Carestream's product development and outreach…

Spotlight

Julia Weidman, Marketing Manager at Carestream, outlines the value of HIMSS Analytics and highlights the services they provided which enhanced Carestream's product development and outreach…

Related News

FUTURE OF HEALTHCARE

Medtronic and DaVita Together Launch a New Kidney Health Tech Company

Medtronic plc | May 27, 2022

Medtornic, the Dublin-based leading provider of healthcare technology, announced a partnership with DaVita, a premier national provider focused on kidney health. Through the partnership, both organizations aim to form a medical device company called NewCo that specializes in kidney care. "This is an exciting moment that will shape the future of kidney care. Our singular focus on end-to-end kidney health solutions will position this new company to make a measurable difference in the lives of more than three million patients with kidney failure globally—a figure expected to double over the next decade." Ven Manda, president of Medtronic's RCS business and NewCo's CEO By combining Medtronic’s proficiency in healthcare technology with DaVita’s extensive expertise in holistic kidney care solutions. NewCo will emphasize the development of cutting-edge kidney care products.” “The firm is well-positioned to further the promotion of differentiated kidney therapies. "We're excited to collaborate with Medtronic and share our deep insight into patient and physician needs with the goal of accelerating the development and commercialization of scalable kidney care technologies. DaVita is committed to best-in-class solutions that improve outcomes, access, and the quality of life of our patients, and this is another way to provide more options to the market." Javier Rodriguez, CEO of DaVita

Read More

HEALTH TECHNOLOGY

Tabula Enters Agreement to Sell PrescribeWellness to Transaction Data Systems

Tabula Rasa HealthCare, Inc. | June 22, 2022

Premier healthcare technology provider Tabula Rasa HealthCare has announced that it has agreed to sell the PrescribeWellness business to cutting edge patient relationship management provider, Transaction Data Systems. "Today's announcement is a significant, strategic step forward in unlocking stockholder value, while extending the reach of our MedWise Science through TDS's strong network. We embarked on a robust search for the right organization to best serve our customers and employees and believe that we have found an excellent partner to advance the future of pharmacy by leveraging these technologies. We anticipate that this divestiture, coupled with our strategic partnership, will position TRHC for accelerated growth and increased stockholder value." Calvin H. Knowlton, PhD, TRHC Chairman and CEO Tabula Rasa is committed to promoting the safe use of medicines while TDS delivers patient-oriented solutions with a focus on pharmacy systems. TDS is currently supporting an installation of Rx30 and Computer Rx-systems in over 50 states. "At TDS, we are dedicated to providing pharmacists with the tools to address their critical and expanding role in delivering high-quality patient care. Adding PrescribeWellness to our existing suite of industry-leading PMS and patient-centric solutions will enable our pharmacist customers to engage with patients, ensure access to the right therapies, drive medication adherence, improve outcomes, boost patient loyalty and generate incremental pharmacy revenue. This acquisition, our ongoing collaboration with MedWise and TRHC, and our commitment to innovation will secure our pharmacy customers' position as primary providers in the evolving nexus of clinical care." Jude Dieterman, CEO of Transaction Data Systems

Read More

HEALTH TECHNOLOGY

MedSec Sets Up a Healthcare Technology Cyber Risk Management Team

MedSec | July 04, 2022

In order to increase its biological and clinical knowledge, MedSec, a premier solutions provider of medical device security, announced it is forming a new Healthcare Technology Cyber Risk Management (HTCRM) team with a roster of seasoned professionals in the sector. The present Chief Product Officer of MedSec and HTCRM authority Phil Englert will take on the position of Advisor for the new team. "MedSec serves stakeholders of all kinds within the medical device eco-system. The establishment of this team allows us to better serve our hospital clients, who are tackling medical device security on a day-to-day basis." Justine Bone, CEO at MedSec "Biomedical and Clinical Engineering teams already have too many things on their plate – and they need leverage. Becoming an extension of their team, augmented by our technology capabilities, we're able to help our customers do things that they would otherwise not be capable of doing with their existing staff. Our clients love the combination of being able to 'speak tech' but also 'understand clinical' to help them further achieve their goals." Andrew Donarumo, Chief Technology Officer at MedSec Englert will continue to assist MedSec in creating security options for hospitals as an advisor. Englert brings to the position extensive understanding of clinical settings and medical technologies. His experience covers more than 30 years of technical and operational leadership in the healthcare and life sciences sector with an emphasis on creating strategic direction, enhancing operations, and undertaking business optimization and transformation efforts that are enabled by data and technology. In addition to governance and operations, vulnerability and patch management, incident response, medical device alerts, and SOC integration, Phil has led the development of medical device security programmes that have made it possible to prioritise strategic initiatives that will have an impact and carry out efficient maintenance and response tasks. In the past, he oversaw the development of strategy and tactics for a $250 million MedTech services business that supported over 130 Acute Care hospitals in 22 states.

Read More